CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRLCharles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 5, 2026
6dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Other
Charles River CEO Jim Foster is retiring on May 5, 2026, after over 30 years in the position. Samsung Bio is acquiring a manufacturing facility from GlaxoSmithKline.
No drugs found in this phase.